<div id="readability-page-1">Bristol-Myers Squibb (BMY) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5% in the preceding six sessions. The stock is down 5% over the past one month, while it has advanced 4% so far this year. Most recently, Bristol-Myers Squibb reported better-than-expected Q1 2...</div>

百時美施貴寶

醫療業 ETF - SPDR

納斯達克生物科技指數 ETF - iShares Nasdaq

<p>百時美施貴寶（BMY）股票連續七個交易日下跌，週一下跌 0.9%，報 55.64 美元。該股在之前六個交易日中下跌了 3.5%，過去一個月下跌了 5%，儘管年初至今上漲了 4%。該公司最近公佈的第一季度業績好於預期</p>

Bristol-Myers Squibb shares fell for seventh consecutive session

醫藥 3 倍做多 - Direxion

醫藥突破 ETF - ALPS

2 倍做多納斯達克生物技術 ETF - ProShares

美國制藥 ETF - iShares

基因改革 ETF - ARK

動態生物技術與基因組 ETF - Invesco

生物科技 ETF - VanEck Vectors

標普全球醫療股指數 ETF - iShares

2 倍做空衞生保健 ETF - ProShares

醫療業 ETF - Vanguard

Invesco Nasdaq Biotechnology ETF

標普生物技術 ETF - SPDR

標普生物技術 3 倍做多 - Direxion

紐交所高增長板生物技術指數 ETF - First Trust

Bristol-Myers Squibb Company

百時美施貴寶的股價已經連續七個交易日下跌